Successful Treatment by Radiation and Hormone Therapy of Isolated Local Recurrence of Breast Cancer 24 Years after Mastectomy Accompanied by Immune Thrombocytopenia: A Case Report

Japanese Journal of Clinical Oncology

Volumn 28, Issue 4, 1998, Pages 270-275

  Igarashi, Tadahiko ^a   Itoh, Kuniaki ^a   Fuji, Hirofumi ^a   Ohtsu, Tomoko ^a   Minami, Hironobu ^a   Sasaki, Yasutsuna ^a   Shimizu, Wakako ^a   Ogino, Takashi ^a   Muramatsu, Masahisa ^b  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b Department of Surgery   (Japan)

Author keywords

Breast cancer; Idiopathic thrombocytopenic purpura; Local recurrence; Radiation

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; TAMOXIFEN;

ADENOCARCINOMA; AGED; BREAST TUMOR; CASE REPORT; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MASTECTOMY; PARAPROTEINEMIA; RADIATION DOSE; RADIOGRAPHY; REVIEW; TIME; TUMOR RECURRENCE;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY; NEOPLASM RECURRENCE, LOCAL; PARAPROTEINEMIAS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RADIOTHERAPY DOSAGE; TAMOXIFEN; TIME FACTORS;

EID: 0032038544     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/28.4.270     Document Type: Article

References (38)

1. Kim HD, Boggs DR. A syndrome resembling idiopathic thrombocytopenic pupura in 10 patients with diverse forms of cancer. Am J Med 1979;67:371-7.
2. Bellone JD, Kunicki TJ, Aster RH. Immune thrombocytopenia associated with carcinoma. Ann Intern Med 1983;99:470-2.
3. Schwartz KA, Slichter SJ, Harker LA. Immune-mediated platelet destruction and thrombocytopenia in patients with solid tumors Br J Haematol 1982;51:17-24.
4. Fink K, Al-Mondhiry H. Idiopathic thrombocytopenic purpura in lymphoma. Cancer 1976;37:1999-2004.
5. Kaden BR, Rosse WF, Hauch TW. Immune thrombocytopenia in lymphoproliferative diseases. Blood 1979;53:545-51.
6. Woods VL Jr, Kurata Y, Montgomery RR, Tani P, Mason D, Oh EH. et al Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura. Blood 1984;64:156-60.
7. Berkman AW, Kickler T, Braine H. Platelet-associated IgG in patients with lymphoma. Blood 1984;63.944-8.
8. McMillan R, Tani P, Millard F, Berchtold P, Renshaw L, Woods VL Jr. Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic FTP. Blood 1987;70:1040-5.
9. Essers U, Angelkort B. Microangiopathic hemolytic-thrombopenic purpura in metastasizing breast carcinoma. Successful therapy by chemotherapy. Blut 1980;40:157-9.
10. Kobayashi H, Kitano K, Ishida F, Saito H, Miyabayashi H, Yonezawa T. et al. Aplastic anemia and idiopathic thrombocytopenic purpura with antibody to platelet glycoprotein IIb/IIIa following resection of malignant thymoma. Acta Haematol 1993;90:42-5.
11. Kaneko Y, Murakami H, Matsushima T, Tamura J, Sawamura M, Karasawa M. et al. Idiopathic thrombocytopenic purpura and monoclonal gammopathy of undetermined significance accompanied by urinary bladder carcinoma (letter). Clin Exp Rheumatol 1993;11:217.
12. Ohura H, Sagawa M, Yoshida H, Kondo T, Matsumura Y, Saito R. et al. A case of idiopathic thrombocytopenic purpura combined with lung cancer. Nippon Kyobu Geka Gakkai Zasshi 1996;49:484-6 (in Japanese).
13. Saunders P, Warenius H. Autoimmune thrombocytopenia in neoplastic disease Br J Haematol 1982;52:339-40.
14. Cunnings OW, Mazur MT. Breast carcinoma diffusely metastatic to the spleen. A report of two cases presenting as idiopathic thrombocytopenic purpura. Am J Clin Pathol 1992;97:484-9.
15. Obrist R, Ludwig C, Kluppelberg J, Obrecht JP Autoimmune thrombocytopenic purpura in malignant lymphoma. Schwetz Med Wochenchr 1985;115:1236-41 (in German).
16. Ciavarella D. The use of protein A columns in the treatment of cancer and allied diseases Int J Clin Lab Res 1992;21:210-13.
17. Doan CA, Bouroncle BA, Wiseman BK. Idiopathic and secondary thrombocytopenic purpura. Clincal study and evaluation of 381 cases over a period of 28 years. Ann Intern Med 1960;53:861-76
18. American Society of Hematology FTP Practice Guideline Panel Diagnosis and treatment of idiopathic thrombocytopenic purpura: recommendations of the American Society of Hematology. Ann Intern Med 1997;126:319-26.
19. Stasi R, Stipa E, Masi M, Cecconi M, Scimo MT, Oliva F. et al. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med 1995;98:436-42.
20. Snyder HW Jr, Seawell BW, Cochran SK, Balint JP Jr, Jones FR. Specificity of antibody responses affected by extracorporeal immunoadsorption of plasma over columns of protein A silica J Clin Apherests 1992;7:110-18.
21. Wong SY, Purdie AT, Han P. Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. Am J Pathol 1992;140:1473-82
22. Olcksowicz L, Dutcher JP. Adhesive receptors expressed by tumor cells and platelets, novel targets for therapeutic anti-metastatic strategies. Med Oncol 1995;12:95-102.
23. Calderoni A, Altermatt HJ, Pirovino M. Autoimmune processes as paraneo- plastic manifestations in familial breast cancer. Disch Med Wochenschr 1994;119:1194-8 (in German)
24. Chen KKY, Montague ED, Oswald MJ. Results of irradiation in the treatment of locoregional breast cancer recurrence. Cancer 1985;56:1269-73.
25. Kennedy MJ, Abeloff MD. Management of locally recurrent breast cancer. Cancer 1993;71:2395-409.
26. Bedwineck J Natural history and management of isolated local-regional recurrence following mastectomy. Semin Radiat Oncol 1994;4:260-9
27. Chu FCH, Lin FJ, Kim JH, Huh SH, Garmatis CJ. Locally recurrent carcinoma of the breast. Cancer 1976;37:2677-81.
28. Stefanik D, Goldberg R, Byrne P, Smith F, Ueno W, Smith L. et al. Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer J Clin Oncol 1985;3:660-5.
29. Borner M, Bacchi M, Goldhirsch A, Grainer R, Harder F, Castiglione M. et al. First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study competing systemic treatment with observation after excision and radiation J Clin Oncol 1994;12:2071-7.
30. Bedwinek JM, Lee J, Fineberg B, Ocwieza M Prognostic indicators in patients with isolated local-regional recurrence of breast cancer. Cancer 1981;47:2232-5.
31. Janjan NA, Mcneese MD, Buzdar AU, Montague ED, Oswald J. Management of locoregional recurrent breast cancer. Cancer 1986;58:1552-6.
32. Valagussa P, Bonadonna G, Veronesi U Patterns of relapse and survival following radical mastectomy, analysis of 716 consecutive patients. Cancer 1978;41:1170-8.
33. Halverson KJ, Perez CA, Kuske RR, Garcia DM, Simpson JR, Fineberg B. Survival following locoregional recurrence of breast cancer univariate and multivariate analysis. Int J Radial Oncol Biol Phys 1992;23:285-91.
34. Tennvall-Nittby L, Tengrup I, Landberg T. The total incidence of loco-regional recurrence in a randomized trial of breast cancer TNM stage II. Acta Oncol 1993;32:641-6.
35. Rubens RD. Age and the treatment of breast cancer. J Clin Oncol 1993;11:3-4.
36. Candido A, Bussa S, Tartaglione R, Mancini R, Rumi C, Rossi P. et al. Tamoxifen-induced immune-mediated platelet destruction. A case report. Tumori 1993;79:231-4.
37. Demicheli R, Terenziani M, Valagussa P, Moliterni A, Zambetti M, Bonadonna G. Local recurrences following mastectomy: support for the concept of tumor dormancy J Natl Cancer Inst 1994;86:45-8
38. Holmgren L, O'Reilly MS, Folkman J Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression Nature Med 1995;1:49-53.